Elacridar-d4 (Major)

• Description :

  Elacridar-d4 (Major) is the deuterium labeled Elacridar (HY-50879) . Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2].

• UNSPSC :

  12352005

• Target :

  BCRP; Isotope-Labeled Compounds; P-glycoprotein

• Related Pathways :

  Membrane Transporter/Ion Channel; Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Smiles :

  O=C(NC1=CC=C(C([2H])(C([2H])(N2CCC(C=C(C(OC)=C3)OC)=C3C2)[2H])[2H])C=C1)C4=CC=CC5=C4NC6=C(C5=O)C=CC=C6OC

• Molecular Formula :

  C34H29D4N3O5

• Molecular Weight :

  567.67

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• CAS Number :

  [1189481-51-3]